Tristan Richard
Publications by Year
Research Areas
Complement system in diseases, DNA Repair Mechanisms, Inflammatory Bowel Disease, Reproductive Biology and Fertility, Renal Transplantation Outcomes and Treatments
Most-Cited Works
- → Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome(2013)1,539 cited
- → Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies(2019)89 cited
- → Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohnʼs disease†(2010)45 cited
- → Therapeutic trials and future advances(2004)2 cited
- → Cinobufotalin as a Novel Agent to Inhibit in-Vitro Epithelial Ovarian Cancer Cell Proliferationc, Migrat Ion and Invasion(2016)
- The Role Of Bca2 In Regulation Of Warburg-Like Glucose And Lactate Metabolism In Breast Cancer Cell Lines(2020)